Provided by Peter Bracke, University of California Los Angeles The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung...
Latest Benzoates Stories
- Patent Covers Taxane Prodrug Nanoparticle Delivery Technology - EWING, N.J., Dec. 18, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
CYRAMZA is the first treatment approved in the U.S. for use in combination with docetaxel in second-line metastatic non-small cell lung cancer INDIANAPOLIS, Dec.
SAN DIEGO, Dec. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS, Nov.
Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct.
CALGARY, Sept. 3, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
SAN DIEGO, July 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) today announced the death of Mr.
BUFFALO, N.Y., July 24, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical
HARBIN, China, July 15, 2014 /PRNewswire/ -- Yew Bio-Pharm Group, Inc.
- A transitional zone between two communities containing the characteristic species of each.